Is Lebraxen a psychotropic drug?

It's a psychotropic drug

Leborexan is a drug for the treatment of insomnia. It has been approved in the United States, Japan, Canada, Australia and some Asian countries for the treatment of adult insomnia, so it is a psychotropic drug.

Insomnia is a complex sleep disorder that affects quality of life, affecting approximately 10% of the population. Insomnia is defined as difficulty initiating or maintaining sleep, associated with impairment or distress in daytime functioning, and is treated with a comprehensive approach consisting of cognitive behavioral therapy and pharmacotherapy.

Lemborexant, a dual orexin receptor antagonist, is a new pharmacotherapy option that was recently approved for the treatment of insomnia. Lemborexant has a low dependence potential, has a small muscle relaxing effect, and has a small impact on cognitive function.

Lemborexant is also a drug that regulates sleep-wake rhythms without causing extrapyramidal symptoms. Based on its ability to improve sleep, it is expected to be effective in insomnia accompanied by delirium.

LeBron

The recommended dose of leborexan is 5 mg, taken no more than once per night, before bed, at least 7 hours before your planned wake-up time. If taken with or shortly after a meal, it may delay the time it takes to fall asleep.

The dose may be increased based on clinical response to the maximum recommended dose of 10 mg. This drug is not recommended for patients with severe hepatic impairment.

Things to note

Lemborexant is a central nervous system (CNS) depressant that can cause central nervous system depression and daytime impairment, so patients should use it according to the instructions or as directed by a doctor.

Lemborexant should not be used in patients with narcolepsy. It should also not be used with other central nervous system depressants, such as benzodiazepines, opioids, tricyclic drugs, antidepressants, and alcohol, which will increase the risk of central nervous system depression and lead to daytime disorders.

Patients may also experience sleep paralysis, an inability to move or speak for several minutes during the sleep-wake transition, and hypnotic or hypnotic hallucinations, including vivid and disturbing sensations.

Patients should fully understand the adverse reactions that may be caused by the drug before taking the medication to avoid accidents during the medication process.

Recommended related articles: